» Articles » PMID: 33492978

Similarities and Dissimilarities of COVID-19 and Other Coronavirus Diseases

Overview
Publisher Annual Reviews
Specialty Microbiology
Date 2021 Jan 25
PMID 33492978
Citations 43
Authors
Affiliations
Soon will be listed here.
Abstract

In less than two decades, three deadly zoonotic coronaviruses, severe acute respiratory syndrome coronavirus (SARS-CoV), Middle East respiratory syndrome coronavirus (MERS-CoV), and SARS-CoV-2, have emerged in humans, causing SARS, MERS, and coronavirus disease 2019 (COVID-19), respectively. The current COVID-19 pandemic poses an unprecedented crisis in health care and social and economic development. It reinforces the cruel fact that CoVs are constantly evolving, possessing the genetic malleability to become highly pathogenic in humans. In this review, we start with an overview of CoV diseases and the molecular virology of CoVs, focusing on similarities and differences between SARS-CoV-2 and its highly pathogenic as well as low-pathogenic counterparts. We then discuss mechanisms underlying pathogenesis and virus-host interactions of SARS-CoV-2 and other CoVs, emphasizing the host immune response. Finally, we summarize strategies adopted for the prevention and treatment of CoV diseases and discuss approaches to develop effective antivirals and vaccines.

Citing Articles

Deep profiling of B cells responding to various pathogens uncovers compartments in IgG memory B cell and antibody-secreting lineages.

Claireaux M, Elias G, Kerster G, Kuijper L, Duurland M, Paul A Sci Adv. 2025; 11(8):eado1331.

PMID: 39970201 PMC: 11837990. DOI: 10.1126/sciadv.ado1331.


Profiling of coronaviral M and enteroviral 3C specificity provides a framework for the development of broad-spectrum antiviral compounds.

Rut W, Groborz K, Sun X, Hilgenfeld R, Drag M Protein Sci. 2024; 33(9):e5139.

PMID: 39150063 PMC: 11328108. DOI: 10.1002/pro.5139.


Innate Immunity in Protection and Pathogenesis During Coronavirus Infections and COVID-19.

Malireddi R, Sharma B, Kanneganti T Annu Rev Immunol. 2024; 42(1):615-645.

PMID: 38941608 PMC: 11373870. DOI: 10.1146/annurev-immunol-083122-043545.


Heterotypic immunity from prior SARS-CoV-2 infection but not COVID-19 vaccination associates with lower endemic coronavirus incidence.

Bean D, Monroe J, Liang Y, Borberg E, Senussi Y, Swank Z Sci Transl Med. 2024; 16(751):eado7588.

PMID: 38865483 PMC: 11565543. DOI: 10.1126/scitranslmed.ado7588.


Design and Application of Biosafe Coronavirus Engineering Systems without Virulence.

Wu G, Li Q, Dai J, Mao G, Ma Y Viruses. 2024; 16(5).

PMID: 38793541 PMC: 11126016. DOI: 10.3390/v16050659.